Systemic lupus erythematosus with visceral varicella: A case report. 2022

Jing Zhao, and Mei Tian
Department of Rheumatology, Affiliated Hospital of Zunyi Medical University, Zunyi 563003, Guizhou Province, China.

BACKGROUND As an autoimmune disease, systemic lupus erythaematosus (SLE) can affect multiple systems of the body and is mainly treated by steroids and immunosuppressive agents. SLE results in a long-term immunocompromised state with the potential of infection complications (e.g., bacterial, fungal and viral infections). Abdominal pain or acute abdomen are frequently the only manifestations of SLE at disease onset or during the early stage of the disease course. Thus, multidisciplinary collaboration is required to identify these patients because timely diagnosis and treatment are crucial for improving their prognosis. METHODS Herein, we reported a case of an SLE patient with visceral varicella that was identified after the onset of abdominal pain. The 16-year-old female patient with SLE was admitted to our hospital due to initial attacks of abdominal pain and intermittent fever. The patient's condition rapidly became aggravated within a short time after admission, with large areas of vesicular rash, severe pneumonia, respiratory failure, shock, and haematologic system and hepatic function impairment. Based on multidisciplinary collaboration, the patient was diagnosed with visceral disseminated varicella and was administered life support, antiviral (acyclovir), immunomodulatory (intravenous injection of human immunoglobulin), anti-infection (vancomycin) and anti-inflammatory (steroid) therapies. After treatment, her clinical symptoms and laboratory indicators gradually improved, and the patient was discharged. CONCLUSIONS SLE patients long treated with steroids and immunosuppressive agents are susceptible to various infections. Considering that visceral varicella with abdominal pain as the initial presentation is characterized by rapid progression and often coexists with serious complications, prompt diagnosis and early antiviral therapy are critical to prevent severe life-threatening complications.

UI MeSH Term Description Entries

Related Publications

Jing Zhao, and Mei Tian
October 1970, Geka chiryo. Surgical therapy,
Jing Zhao, and Mei Tian
July 1996, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed,
Jing Zhao, and Mei Tian
October 1999, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology,
Jing Zhao, and Mei Tian
December 1969, Indian journal of pediatrics,
Jing Zhao, and Mei Tian
March 1977, The Journal of the Royal College of General Practitioners,
Jing Zhao, and Mei Tian
June 2023, Cureus,
Jing Zhao, and Mei Tian
January 2019, Autopsy & case reports,
Jing Zhao, and Mei Tian
September 2015, Experimental and therapeutic medicine,
Jing Zhao, and Mei Tian
February 2021, The Journal of international medical research,
Copied contents to your clipboard!